Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/1999
09/14/1999US5952201 Method of preparing oligonucleotide probes or primers, vector therefor and use thereof
09/14/1999US5952199 A protein that contains an immunoglobulin-like domain; antiproliferative/antitumor agents, treatment of rheumatoid arthritis, psoriasis, diabeties, glaucoma, muscular disorders and immune rejection of eye transplants
09/14/1999US5952198 Production of recombinant Factor VIII in the presence of liposome-like substances of mixed composition
09/14/1999US5952197 DNA encoding the chemotactic cytokine III
09/14/1999US5952195 A nucleic acid fragment having transcriptional promoter activity; for the production of commerical or therapeutic polypeptides of interest in biotechnology
09/14/1999US5952194 Flea nucleic acid sequences and uses thereof
09/14/1999US5952187 Antiepileptic agent analog derivatized at the sulfamate moiety or the 9-carbon methyl group to add label for use in immunoassays or to add carrier for use as immunogen; for monitoring serum or plasma levels of drug
09/14/1999US5952181 Hybridizing polynucleotide sequence to complementary polynucleotide forming a complex, detecting complex formation; anticarcinogenic agent, treatment of psychological disorders, alzheimer's disease
09/14/1999US5952180 Sets of labeled energy transfer fluorescent primers and their use in multi component analysis
09/14/1999US5952179 Screens for mutations in the anti-proliferation domain of human Bcl-2
09/14/1999US5952176 Glycosylase mediated detection of nucleotide sequences at candidate loci
09/14/1999US5952175 DNA encoding a human progesterone receptor complex p23-like protein
09/14/1999US5952174 Ligase/polymerase-mediated genetic bit analysis of single nucleotide polymorphisms and its use in genetic analysis
09/14/1999US5952171 Ligating mammalian cdna to dna encoding alkaline phosphatase lacking signal sequences and membrane anchor sequences, transforming bacterial cells, isolating dna, transfecting mammal cells, isolating cdna clone expressing signal sequence
09/14/1999US5952169 Identification of DNA-damaging substances by means of cell lines capable of overexpressing poly (ADP-ribose)--polymerase
09/14/1999US5952011 Human placental transglutaminase polypeptide and nucleotide sequences encoding it, or an allelic variant thereof; use as wound-healing agent
09/14/1999US5952002 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor
09/14/1999US5951986 Tandem synthetic HIV-1 peptides
09/14/1999US5951979 Mutants (alanine replacing an aspartic acid) lack or have reduced catalytic activity but retain ability to bind substrate resulting in formation of observable and isolatable complex and less immunogenic effects
09/14/1999US5951976 Vaccinating a mammal by administering a composition comprising an opsonin-enhanced cell comprising said selected antigen with the provision the opsonin does not bind to a receptor for a fragment of c33
09/14/1999US5951973 Use of interleukin-4 (IL-4) to treat rheumatoid arthritis
09/14/1999US5951455 Antisense modulation of G-alpha-11 expression
09/14/1999CA2198125C Cytoplasmic male sterility system producing canola hybrids
09/14/1999CA2170869C Amine-derivatized nucleosides and oligonucleosides
09/14/1999CA2132208C Method of eliminating inhibitory/instability regions of mrna
09/14/1999CA2079229C Ubiquitin-specific protease
09/14/1999CA2071446C Synthetic catalytic oligonucleotide structures
09/14/1999CA2012732C Production of modified pe40
09/14/1999CA1340748C Synthetic hiv protease gene and method for its expression
09/14/1999CA1340747C Hiv-2 virus variants
09/14/1999CA1340746C Cloning and expression vectors in an actinomycete strain; process for modifying said strain; actinomycete strain thus obtained and process for preparing proteins
09/14/1999CA1340741C Cloned genes encoding ig-cd4 fusion protiens and the use thereof
09/14/1999CA1340740C Co-expression in eukaryotic cells
09/14/1999CA1340739C Process for transforming plant protoplasts
09/14/1999CA1340736C Method for genetically modifying a plant cell for plant gene expression
09/14/1999CA1340733C Regulatory region for heterologous gene expression in yeast
09/14/1999CA1340732C Sv40 expression vector containing hbxag as an expression marker
09/13/1999CA2265239A1 Genetically engineered l-sorbose reductase-deficient mutants
09/11/1999CA2253946A1 Method for regulating cell death
09/10/1999WO1999045358A2 Identification and expression of human kir5.1
09/10/1999WO1999045155A2 Oligonucleotides for the amplification and detection of epstein barr virus (ebv) nucleic acid
09/10/1999WO1999045154A1 Production and use of normalized dna libraries
09/10/1999WO1999045152A1 Methods for identifying polycationic, peptide-like compounds with antibacterial activity
09/10/1999WO1999045151A1 Methods for detecting, selecting and cloning agents that degrade or promote degradation of dna
09/10/1999WO1999045150A1 Mass spectrometric methods for biomolecular screening
09/10/1999WO1999045149A1 Tagged ligand arrays for identifying ligand-target interactions
09/10/1999WO1999045148A1 Method for using a quality metric to assess the quality of biochemical separations
09/10/1999WO1999045146A1 Zymogenic nucleic acid detection methods, and related molecules and kits
09/10/1999WO1999045145A1 Screening for functional antisense agents
09/10/1999WO1999045144A1 Screening for functional antisense agents
09/10/1999WO1999045143A2 A fluorescence polarization screening method
09/10/1999WO1999045135A1 Novel fdrg protein and nucleic acid molecules and uses therefor
09/10/1999WO1999045132A1 Poly zinc finger proteins with improved linkers
09/10/1999WO1999045130A1 Baculovirus expression system and method for high throughput expression of genetic material
09/10/1999WO1999045129A1 Method for the induction of pathogen resistance in plants
09/10/1999WO1999045127A2 Enhanced prodrug activation
09/10/1999WO1999045126A2 Enhanced prodrug activation
09/10/1999WO1999045125A2 Methods and compositions for regulating cell death and enhancing disease resistance to plant pathogens
09/10/1999WO1999045124A2 Modified forms of pullulanase
09/10/1999WO1999045123A1 Recombinant staphylococcus thioredoxin reductase, and inhibitors thereof useful as antimicrobial agents
09/10/1999WO1999045122A1 Modification of fatty acid metabolism in plants
09/10/1999WO1999045121A1 EPITOPE PEPTIDES IMMUNOGENIC AGAINST $i(STREPTOCOCCUS PNEUMONIAE)
09/10/1999WO1999045120A2 Attenuation of bacteria: materials and methods relating thereto
09/10/1999WO1999045119A2 Production of mycobacterial polypeptides by lactic acid bacteria
09/10/1999WO1999045118A1 Genetic sequences conferring pathogen resistance in plants and uses therefor
09/10/1999WO1999045117A2 Interferon, ifn-hy and uses thereof
09/10/1999WO1999045116A2 Human homolog of a nuclear migration gene and its use
09/10/1999WO1999045115A1 Human synapse related glycoproteins (hsrp)
09/10/1999WO1999045114A2 Human semaphorin zsmf-7
09/10/1999WO1999045113A1 Smad binding elements and uses thereof
09/10/1999WO1999045112A2 Chromosome 11-linked coronary heart disease susceptibility gene chd1
09/10/1999WO1999045111A1 Lectomedin materials and methods
09/10/1999WO1999045110A1 V-like domain binding molecules
09/10/1999WO1999045109A1 Animal model with disrupted fgf-9 gene
09/10/1999WO1999045108A2 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines
09/10/1999WO1999045107A1 Novel calpain and dna encoding the same
09/10/1999WO1999045105A2 Highly crystalline urokinase
09/10/1999WO1999045103A2 Human spinal cord cell lines and methods of use therefor
09/10/1999WO1999045101A1 RESISTANCE IN PLANTS TO INFECTION BY ssDNA VIRUS USING INOVIRIDAE VIRUS ssDNA-BINDING PROTEIN, COMPOSITIONS AND METHODS OF USE
09/10/1999WO1999045100A1 Embryonic or stem-like cell lines produced by cross-species nuclear transplantation
09/10/1999WO1999045098A2 Delivery or proteins into eukaryotic cells with recombinant yersinia
09/10/1999WO1999045031A2 Cd147 binding molecules as therapeutics
09/10/1999WO1999045030A1 Human g-protein coupled receptor (gpr25)
09/10/1999WO1999045019A1 Isolated nucleic acid molecules which encode tage molecules, and uses thereof
09/10/1999WO1999044943A2 Vectors and viruses used in gene therapy
09/10/1999WO1999044644A1 Improved eukaryotic expression vector
09/10/1999WO1999044629A2 Utilization of cd137 in order to promote the proliferation of peripheral monocytes
09/10/1999WO1999044620A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
09/10/1999WO1999044423A1 Amplification of gene transfer and gene therapy by controlled replication
09/10/1999WO1999035263A3 Il-17rh dna and polypeptides
09/10/1999WO1999033991A3 TOXINS ACTIVE AGAINST $i(OSTRINIA NUBILALIS)
09/10/1999WO1999033967A3 Novel nucleic acid and polypeptide with homology to the tnf-receptors
09/10/1999WO1999032644A3 Prostate cancer gene
09/10/1999WO1999032642A3 Method for reduction of transgene copy number
09/10/1999WO1999032622A3 Semaphorin zsmf-3
09/10/1999WO1999032617A3 Expression cloning in filamentous fungi
09/10/1999WO1999032616A3 Method for isolating short and long-chain nucleic acids
09/10/1999WO1999032514A3 Sag: sensitive to apoptosis gene
09/10/1999WO1999031262A3 Needle-free injection of formulated nucleic acid molecules
09/10/1999WO1999031236A3 EXTENDED cDNAs FOR SECRETED PROTEINS